BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.92−0.01 (-0.91%)
Close on Nov 11, 2026Market cap $13.95MP/E –Yield –
BioCardia profit margin
Profit margin (net margin) is net income as a percentage of revenue.
BioCardia's profit margin for the twelve months ending Mar 31, 2025 was -279700.0%. For fiscal 2024 it was -13700.0%, against -2425.8% the year before. The highest annual figure on record is 80516.7% in fiscal 2011.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -13700.0% | −11274.2 |
| FY2023 | Dec 31, 2023 | -2425.8% | −1545.1 |
| FY2022 | Dec 31, 2022 | -880.7% | +363.0 |
| FY2021 | Dec 31, 2021 | -1243.6% | +9103.9 |
| FY2020 | Dec 31, 2020 | -10347.6% | −8275.9 |
| FY2019 | Dec 31, 2019 | -2071.7% | +166.2 |
| FY2018 | Dec 31, 2018 | -2237.9% | +331.6 |
| FY2017 | Dec 31, 2017 | -2569.5% | −779.6 |
| FY2016 | Dec 31, 2016 | -1789.9% | −1049.1 |
| FY2015 | Dec 31, 2015 | -740.8% | −81257.5 |
| FY2011 | Dec 31, 2011 | 80516.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -54866.7% | −46903.9 |
| Q1 FY2024 | Mar 31, 2024 | -4121.8% | +1348.5 |
| Q4 FY2023 | Dec 31, 2023 | -15938.5% | −13081.9 |
| Q3 FY2023 | Sep 30, 2023 | -721.0% | +721.0 |
| Q2 FY2023 | Jun 30, 2023 | -7962.8% | −7706.4 |
| Q1 FY2023 | Mar 31, 2023 | -5470.3% | +71.4 |
| Q4 FY2022 | Dec 31, 2022 | -2856.6% | +1524.4 |
| Q3 FY2022 | Sep 30, 2022 | -1442.0% | −1112.4 |
| Q2 FY2022 | Jun 30, 2022 | -256.4% | +4797.3 |
| Q1 FY2022 | Mar 31, 2022 | -5541.7% | +912.7 |
| Q4 FY2021 | Dec 31, 2021 | -4381.0% | +2116.8 |
| Q3 FY2021 | Sep 30, 2021 | -329.6% | +10988.0 |
| Q2 FY2021 | Jun 30, 2021 | -5053.6% | +8179.7 |
| Q1 FY2021 | Mar 31, 2021 | -6454.3% | +5635.1 |
| Q4 FY2020 | Dec 31, 2020 | -6497.8% | −4869.5 |
| Q3 FY2020 | Sep 30, 2020 | -11317.6% | −9363.0 |
| Q2 FY2020 | Jun 30, 2020 | -13233.3% | −8872.9 |
| Q1 FY2020 | Mar 31, 2020 | -12089.5% | −10392.7 |
| Q4 FY2019 | Dec 31, 2019 | -1628.4% | +1907.6 |
| Q3 FY2019 | Sep 30, 2019 | -1954.6% | +2264.4 |
| Q2 FY2019 | Jun 30, 2019 | -4360.5% | −3014.4 |
| Q1 FY2019 | Mar 31, 2019 | -1696.8% | +104.2 |
| Q4 FY2018 | Dec 31, 2018 | -3535.9% | −49.9 |
| Q3 FY2018 | Sep 30, 2018 | -4219.0% | −1910.6 |
| Q2 FY2018 | Jun 30, 2018 | -1346.0% | +1283.4 |
| Q1 FY2018 | Mar 31, 2018 | -1801.0% | +298.3 |
| Q4 FY2017 | Dec 31, 2017 | -3486.0% | −871.4 |
| Q3 FY2017 | Sep 30, 2017 | -2308.5% | – |
| Q2 FY2017 | Jun 30, 2017 | -2629.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -2099.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -2614.6% | – |
See a number that looks wrong?